Systematic review of cost-of-illness studies in hand eczema

Contact Dermatitis

Volumn 75, Issue 2, 2016, Pages 67-76

  Politiek, Klaziena ^a   Oosterhaven, Jart A F ^a   Vermeulen, Karin M ^a   Schuttelaar, Marie Louise A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

cost of illness; hand eczema; health economics; societal costs; systematic review

Indexed keywords

EMOLLIENT AGENT; NON PRESCRIPTION DRUG;

ABSENTEEISM; COST OF ILLNESS; DISEASE SEVERITY; HAND ECZEMA; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; MEDICAL LEAVE; OUTPATIENT CARE; PATIENT REFERRAL; PRESENTEEISM; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; ULTRAVIOLET IRRADIATION;

EID: 84977638744     PISSN: 01051873     EISSN: 16000536     Source Type: Journal    
DOI: 10.1111/cod.12590     Document Type: Review

References (26)

1. Thyssen J P, Johansen J D, Linneberg A, Menné T. The epidemiology of hand eczema in the general population – prevalence and main findings. Contact Dermatitis 2010: 62: 75–87.
2. Coenraads P J. Hand eczema. N Engl J Med 2012: 367: 1829–1837.
3. Moberg C, Alderling M, Meding B. Hand eczema and quality of life: a population-based study. Br J Dermatol 2009: 161: 397–403.
4. Petersen A H, Johansen J D, Hald M. Hand eczema – prognosis and consequences: a 7-year follow-up study. Br J Dermatol 2014: 171: 1428–1433.
5. Mälkönen T, Alanko K, Jolanki R et al. Long-term follow-up study of occupational hand eczema. Br J Dermatol 2010: 163: 999–1006.
6. Boehm D, Schmid-Ott G, Finkeldey F et al. Anxiety, depression and impaired health-related quality of life in patients with occupational hand eczema. Contact Dermatitis 2012: 67: 184–192.
7. Liberati A, Altman D G, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009: 6: e1000100.
8. Larg A, Moss J R. Cost-of-illness studies: a guide to critical evaluation. Pharmacoeconomics 2011: 29: 653–671.
9. Hakkaart-van Roijen L, Tan S, Bouwmans CAM. Handleiding voor kostenonderzoek, methoden en standaard kostprijzen voor economische evaluaties in de gezondheidszorg. College voor Zorgverzekeringen Geactualiseerde versie. 2010.
10. Onukwugha E, McRae J, Kravetz A et al. Cost-of-illness studies: an updated review of current methods. Pharmacoeconomics 2016: 34: 43–58.
11. Rothfuss J, Mau W, Zeidler H, Brenner M H. Socioeconomic evaluation of rheumatoid arthritis and osteoarthritis: a literature review. Semin Arthritis Rheum 1997: 26: 771–779.
12. Zhu T Y, Tam L S, Li E K. Cost-of-illness studies in systemic lupus erythematosus: a systematic review. Arthritis Care Res (Hoboken) 2011: 63: 751–760.
13. Drummond M F, Sculpher M, Claxton K et al. Critical assessment of economic evaluation. In: Methods for the Economic Evaluation of Health Care Programmes, 4th edition: New York, Oxford University Press, 2015: pp. 41–76.
14. Cortesi P A, Scalone L, Belisari A et al. Cost and quality of life in patients with severe chronic hand eczema refractory to standard therapy with topical potent corticosteroids. Contact Dermatitis 2013: 70: 158–168. doi: 10.1111/cod. 12130.
15. Augustin M, Kuessner D, Purwins S et al. Cost-of-illness of patients with chronic hand eczema in routine care: results from a multicentre study in Germany. Br J Dermatol 2011: 165: 845–851.
16. Diepgen T L, Scheidt R, Weisshaar E et al. Cost of illness from occupational hand eczema in Germany. Contact Dermatitis 2013: 69: 99–106.
17. Diepgen T L, Purwins S, Posthumus J et al. Cost-of-illness analysis of patients with chronic hand eczema in routine care in Germany: focus on the impact of occupational disease. Acta Derm Venereol 2013: 93: 538–543.
18. Fowler J F, Ghosh A, Sung J et al. Impact of chronic hand dermatitis on quality of life, work productivity, activity impairment, and medical costs. J Am Acad Dermatol 2006: 54: 448–457.
19. van Gils R F, Bosmans J E, Boot C R et al. Economic evaluation of an integrated care programme for patients with hand dermatitis. Contact Dermatitis 2013: 69: 144–152.
20. Diepgen T L, Andersen K E, Chosidow O et al. Guidelines for diagnosis, prevention and treatment of hand eczema. J Dtsch Dermatol Ges 2015: 13: e1–e22.
21. Collins J J, Baase C M, Sharda C E et al. The assessment of chronic health conditions on work performance, absence, and total economic impact for employers. J Occup Environ Med 2005: 47: 547–557.
22. Ospina M B, Dennett L, Waye A et al. A systematic review of measurement properties of instruments assessing presenteeism. Am J Manag Care 2015: 21: e171–e185.
23. Bouwmans C, Krol M, Severens H et al. The iMTA Productivity Cost Questionnaire: a standardized instrument for measuring and valuing health-related productivity losses. Value Health 2015: 18: 753–758.
24. Terwee C B, Mokkink L B, Knol D L et al. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 2012: 21: 651–657.
25. Krol M, Brouwer W, Rutten F. Productivity costs in economic evaluations: past, present, future. Pharmacoeconomics 2013: 31: 537–549.
26. Ruzicka T, Lynde C W, Jemec G B et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008: 158: 808–817.